Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+24.8% YoY

Gross Profit

$3M64.2% margin

Operating Income

-$4M-76.8% margin

Net Income

-$4M-78.7% margin

EPS (Diluted)

$-0.17

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$899,000

Balance Sheet

Total Assets

$62M

Total Liabilities

$16M

Stockholders' Equity

$46M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$4M	+24.8%
Gross Profit	$3M	$3M	+23.6%
Operating Income	-$4M	-$2M	-77.2%
Net Income	-$4M	-$3M	-56.0%

Revenue Segments

Functional Neurosurgery Navigation and Therapy

$2M22%

Biologics And Drug Delivery

$2M21%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M19%

Biologics And Drug Delivery - Services

$1M13%

Biologics And Drug Delivery - Disposable Products

$850,0008%

Capital Equipment And Software

$639,0006%

Capital Equipment And Software - Systems and Software Products

$450,0004%

Functional Neurosurgery Navigation and Therapy - Services

$375,0004%

Capital Equipment And Software - Services

$189,0002%